Clinical trial
Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
NCT03514381 is registered in ClinicalTrials.gov with Institut Claudius Regaud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacologic Interaction Between Ifosfamide and Aprepitant in Treated Patients With Soft Tissue Sarcoma
- Lead sponsor
- Institut Claudius Regaud
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- May 18, 2018
- Completion date
- November 23, 2020
- Enrollment
- 59 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
soft tissue sarcoma